Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study)

A prospective randomized study was undertaken to determine whether the administration of oral contraceptives after the evacuation of a hydatidiform mole affects the human chorionic gonadotropin serum level in a way that leads to an increased frequency in the diagnosis of postmolar trophoblastic disease. Between 1981 and 1988, 266 patients were randomly assigned to either oral contraceptives or barrier contraception after evacuation of a hydatidiform mole. Patients were followed up until serum levels of human chorionic gonadotropin were normal or until specific criteria for the diagnosis of postmolar trophoblastic disease were met. Twenty-three percent of patients receiving oral contraceptives had postmolar trophoblastic disease, whereas those using a barrier method had a rate of 33%. The median time to spontaneous regression in the oral contraceptives group was 9 weeks, whereas the median time to regression in the barrier group was 10 weeks. Twice as many patients in the barrier group became pregnant in the immediate follow-up period. We conclude that oral contraceptives are the preferred method of contraception after evacuation of a hydatidiform mole.
AuthorsS L Curry, J B Schlaerth, E I Kohorn, J B Boyce, H Gore, L B Twiggs, J A Blessing
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 160 Issue 4 Pg. 805-9; discussion 809-11 (Apr 1989) ISSN: 0002-9378 [Print] UNITED STATES
PMID2540654 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Chorionic Gonadotropin
  • Contraceptive Agents, Female
  • Contraceptives, Oral, Hormonal
  • Chorionic Gonadotropin (blood)
  • Contraceptive Agents, Female (pharmacology)
  • Contraceptives, Oral, Hormonal (adverse effects)
  • Female
  • Humans
  • Hydatidiform Mole (complications)
  • Pregnancy
  • Prospective Studies
  • Random Allocation
  • Retrospective Studies
  • Trophoblastic Neoplasms (blood, diagnosis, etiology)
  • Uterine Neoplasms (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: